UBS Upgrades Accenture to Buy, Maintains Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Mcveigh has upgraded Accenture (NYSE:ACN) from Neutral to Buy, maintaining the price target at $400.
July 19, 2024 | 2:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Kevin Mcveigh has upgraded Accenture (NYSE:ACN) from Neutral to Buy, maintaining the price target at $400.
The upgrade from Neutral to Buy by a reputable analyst at UBS is likely to positively impact Accenture's stock price in the short term. Maintaining the price target at $400 suggests confidence in the company's current valuation and future prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100